← Back to Search

Depression Care Management for Depression

N/A
Waitlist Available
Led By Martha L Bruce, PhD, MPH
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 65 years or older
Be older than 65 years old
Must not have
Severe hearing impairment or aphasic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Summary

This trial found that the Depression CAREPATH intervention worked in reducing depression symptoms in older home healthcare patients.

Who is the study for?
This trial is for home healthcare patients aged 65 or older who are experiencing depression, can communicate in English or Spanish, and have been noted to have a depressed mood. It's not suitable for those with significant cognitive issues, very short life expectancy, high suicide risk, or severe communication difficulties due to hearing loss.
What is being tested?
The study is examining the 'Depression CAREPATH' initiative against usual care practices. The CAREPATH aims to improve how nurses help manage depression treatment over time with patient and doctor collaboration. Patient progress will be tracked at several intervals up to one year.
What are the potential side effects?
Since this trial involves care management rather than medication, side effects are not typical as with drug trials. However, there may be emotional or psychological impacts from discussing depressive symptoms regularly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe hearing loss or cannot speak.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Depression Severity
Secondary study objectives
Guideline Consistent change in depression treatment

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Patients under the care of nurses who were trained in depression assessment and usual care
Group II: Depression CAREPATHExperimental Treatment1 Intervention
Patients receiving care from Nurses trained in depression care management

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,077 Previous Clinical Trials
1,320,357 Total Patients Enrolled
67 Trials studying Depression
16,480 Patients Enrolled for Depression
Martha L Bruce, PhD, MPHPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
7,889 Total Patients Enrolled
1 Trials studying Depression
7,800 Patients Enrolled for Depression

Media Library

Depression CAREPATH Clinical Trial Eligibility Overview. Trial Name: NCT01979302 — N/A
Depression Research Study Groups: Depression CAREPATH, Usual Care
Depression Clinical Trial 2023: Depression CAREPATH Highlights & Side Effects. Trial Name: NCT01979302 — N/A
Depression CAREPATH 2023 Treatment Timeline for Medical Study. Trial Name: NCT01979302 — N/A
~19 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top